Astronics Corp Files 8-K on Financials
Ticker: ATROB · Form: 8-K · Filed: Aug 1, 2024 · CIK: 8063
| Field | Detail |
|---|---|
| Company | Astronics Corp (ATROB) |
| Form Type | 8-K |
| Filed Date | Aug 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ATRO
TL;DR
Astronics Corp dropped an 8-K detailing their financials - check it for the latest numbers.
AI Summary
Astronics Corporation filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's financial performance and provides supporting documentation.
Why It Matters
This filing provides investors with crucial updates on Astronix Corporation's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing with no immediate negative or positive news indicated.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's annual financial reporting period.)
- 0-7087 — Commission File Number (Unique identifier for the company's SEC filings.)
Key Players & Entities
- ASTRONICS CORP (company) — Registrant
- NASDAQ (company) — Exchange where common stock is traded
- New York (location) — State of incorporation
- East Aurora (location) — Principal executive offices city
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the header information.
When was this 8-K report filed with the SEC?
The report was filed on August 1, 2024.
What is the trading symbol for Astronix Corporation's common stock?
The trading symbol is ATRO.
On which exchange is Astronix Corporation's common stock listed?
Astronix Corporation's common stock is listed on the NASDAQ.
What is the principal executive office address for Astronix Corporation?
The principal executive offices are located at 130 Commerce Way, East Aurora, New York 14052.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-08-01 16:22:01
Filing Documents
- atro-20240801.htm (8-K) — 22KB
- ex99120240629-pr.htm (EX-99.1) — 339KB
- atrocorp_image1a11.jpg (GRAPHIC) — 41KB
- segmentsalesandbookingsv1.jpg (GRAPHIC) — 572KB
- 0000008063-24-000043.txt ( ) — 1349KB
- atro-20240801.xsd (EX-101.SCH) — 2KB
- atro-20240801_lab.xml (EX-101.LAB) — 21KB
- atro-20240801_pre.xml (EX-101.PRE) — 12KB
- atro-20240801_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 1, 2024 , Astronics Corporation issued a news release announcing its second quarter financial results for 2024. A copy of the press release is attached as Exhibit 99.1. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The information in this report including the exhibit hereto, shall not be deemed to be "filed" for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Description 99.1 Press Release of Astronics Corporation dated August 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Astronics Corporation Dated: August 1, 2024 By: /s/ David C. Burney Name: David C. Burney Executive Vice President and Chief Financial Officer